Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
PG

PG - Procter & Gamble Co-The Stock Price, Fair Value and News

160.55USD+0.15 (+0.09%)Market Closed
Watchlist

Market Summary

USD160.55+0.15
Market Closed
0.09%

PG Alerts

  • 4 major insider sales recently.

PG Stock Price

View Fullscreen

PG RSI Chart

PG Valuation

Market Cap

377.8B

Price/Earnings (Trailing)

25.58

Price/Sales (Trailing)

4.5

Price/Free Cashflow

23.61

PG Price/Sales (Trailing)

PG Profitability

Return on Equity

30.25%

Return on Assets

12.24%

Free Cashflow Yield

4.24%

PG Fundamentals

PG Revenue

Revenue (TTM)

83.9B

Rev. Growth (Yr)

3.22%

Rev. Growth (Qtr)

-1.97%

PG Earnings

Earnings (TTM)

14.8B

Earnings Growth (Yr)

-11.82%

Earnings Growth (Qtr)

-23.29%

Breaking Down PG Revenue

Last 7 days

0.1%

Last 30 days

4.6%

Last 90 days

4.3%

Trailing 12 Months

13.9%

How does PG drawdown profile look like?

PG Financial Health

Current Ratio

0.64

Debt/Equity

0.47

Debt/Cashflow

0.83

PG Investor Care

Dividend Yield

2.33%

Dividend/Share (TTM)

3.74

Buy Backs (1Y)

0.26%

Diluted EPS (TTM)

5.97

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202381.0B82.0B83.3B83.9B
202279.6B80.2B80.5B80.3B
202174.9B76.1B77.1B78.3B
202070.3B71.0B72.5B74.0B
201967.1B67.7B68.8B69.6B
201866.4B66.8B66.9B66.9B
201765.1B65.1B65.2B65.7B
201665.8B65.3B65.3B65.2B
201572.3B70.7B68.5B66.9B
201476.6B74.4B74.4B73.6B
201382.5B82.6B81.0B78.6B
201283.9B83.7B82.5B82.5B
201179.6B81.1B82.8B83.6B
201078.1B78.9B78.9B78.9B
200977.3B76.7B75.5B76.8B
200877.6B79.3B78.6B78.0B
2007072.4B74.1B75.8B

Tracking the Latest Insider Buys and Sells of Procter & Gamble Co-The

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 06, 2024
francisco ma. fatima
acquired
1,963,000
78.52
25,000
ceo - baby, fem & family care
Feb 06, 2024
francisco ma. fatima
sold
-3,975,000
159
-25,000
ceo - baby, fem & family care
Jan 29, 2024
francisco ma. fatima
sold
-7,020,000
156
-45,000
ceo - baby, fem & family care
Jan 29, 2024
francisco ma. fatima
acquired
3,533,400
78.52
45,000
ceo - baby, fem & family care
Jan 25, 2024
jejurikar shailesh
sold
-4,844,500
154
-31,275
chief operating officer
Jan 25, 2024
purushothaman balaji
acquired
1,124,060
80.29
14,000
chief human resources officer
Jan 25, 2024
jejurikar shailesh
acquired
2,511,070
80.29
31,275
chief operating officer
Jan 25, 2024
purushothaman balaji
sold
-2,164,520
154
-14,000
chief human resources officer
Jan 24, 2024
francisco ma. fatima
acquired
5,854,800
91.07
64,289
ceo - baby, fem & family care
Jan 24, 2024
francisco ma. fatima
sold
-11,412,000
153
-74,443
ceo - baby, fem & family care

1–10 of 50

Which funds bought or sold PG recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 21, 2024
Garde Capital, Inc.
added
19.18
137,000
832,000
0.06%
Feb 21, 2024
WNY Asset Management, LLC
added
5.4
71,842
1,291,740
0.22%
Feb 21, 2024
V-Square Quantitative Management LLC
added
97.24
2,430,770
4,907,040
0.87%
Feb 21, 2024
Austin Wealth Management, LLC
added
0.37
83,423
1,964,620
0.53%
Feb 21, 2024
CHELSEA COUNSEL CO
reduced
-13.9
-563,616
3,611,930
1.92%
Feb 21, 2024
Raleigh Capital Management Inc.
added
0.55
13,637
1,334,960
0.62%
Feb 21, 2024
SMITH SHELLNUT WILSON LLC /ADV
reduced
-9.06
-103,026
1,089,670
0.62%
Feb 21, 2024
Novak & Powell Financial Services, Inc.
new
-
1,733,310
1,733,310
1.16%
Feb 21, 2024
American Trust
reduced
-1.7
-57,696
4,603,110
0.34%
Feb 20, 2024
Sunpointe, LLC
new
-
371,626
371,626
0.47%

1–10 of 47

Are Funds Buying or Selling PG?

Are funds buying PG calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PG
No. of Funds

Unveiling Procter & Gamble Co-The's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.54%
224,920,035
SC 13G/A
Jan 29, 2024
blackrock inc.
6.6%
155,762,299
SC 13G/A
Feb 09, 2023
vanguard group inc
9.53%
225,735,413
SC 13G/A
Feb 07, 2023
blackrock inc.
6.7%
159,681,048
SC 13G/A
Feb 09, 2022
vanguard group inc
8.89%
215,125,047
SC 13G/A
Feb 01, 2022
blackrock inc.
6.5%
156,813,284
SC 13G/A
Feb 10, 2021
vanguard group inc
8.79%
217,956,036
SC 13G/A
Jan 29, 2021
blackrock inc.
6.6%
162,134,009
SC 13G/A
Feb 12, 2020
vanguard group inc
8.96%
223,460,608
SC 13G/A
Feb 05, 2020
blackrock inc.
6.7%
168,168,813
SC 13G/A

Recent SEC filings of Procter & Gamble Co-The

View All Filings
Date Filed Form Type Document
Feb 22, 2024
4
Insider Trading
Feb 22, 2024
4
Insider Trading
Feb 21, 2024
144
Notice of Insider Sale Intent
Feb 14, 2024
144
Notice of Insider Sale Intent
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 07, 2024
4
Insider Trading
Feb 01, 2024
144
Notice of Insider Sale Intent
Jan 30, 2024
4
Insider Trading
Jan 29, 2024
8-K
Current Report
Jan 29, 2024
SC 13G/A
Major Ownership Report

What is the Fair Value of PG?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Procter & Gamble Co-The)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
377.8B
83.9B
4.59% 13.92%
25.58
4.5
4.55% 3.44%
70.8B
19.5B
3.18% 13.50%
30.78
3.64
8.29% 28.85%
53.3B
15.2B
8.58% -41.51%
95.84
3.52
-7.33% -74.76%
24.3B
5.9B
0.13% 18.35%
32.15
4.14
3178.16% 82.56%
18.9B
7.3B
5.41% 0.36%
236.69
2.59
3.47% -81.61%
11.6B
6.0B
-2.78% 14.31%
35.88
1.93
14.07% 132.95%
MID-CAP
10.1B
890.1M
10.39% 143.94%
78.24
11.37
79.24% 176.22%
4.8B
1.3B
8.91% 33.38%
30.27
3.7
31.74% 54.03%
3.1B
8.1B
-9.66% -46.45%
-8.03
0.38
-14.02% -296.95%
3.0B
2.0B
0.53% 18.08%
18.47
1.5
-7.82% 10.32%
SMALL-CAP
2.0B
792.6M
17.04% 4.37%
-55.21
2.49
78.34% 58.46%
1.9B
2.3B
0.90% -12.74%
17.99
0.85
4.31% 6.67%
175.7M
193.7M
15.24% 103.88%
29.35
0.91
-1.01% 0.37%
57.8M
273.5M
-13.00% 286.67%
-1.25
0.21
-18.31% 63.14%
37.5M
11.0M
7.89% -24.64%
14.88
3.4
-18.80% -16.08%

Procter & Gamble Co-The News

Latest updates
Yahoo Finance19 Jan 202408:00 am
CNN05 Jan 202403:21 pm

Procter & Gamble Co-The Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-2.0%21,44121,87120,55320,06820,77320,61219,51519,38120,95320,33818,94618,10919,74519,31817,69817,21418,24017,79817,09416,46217,438
  S&GA Expenses-1.5%5,5225,6045,7785,4165,0914,8275,1155,0315,1214,9505,6155,4025,1124,8955,2755,0454,8894,7855,0034,8064,623
Interest Expenses10.2%248225240222171123115109106109117106143136157100100108111131138
Income Taxes-19.5%1,0031,2468418648761,034592704997909656628990989675541789726172502700
Net Income-23.3%3,4684,5213,3843,3973,9333,9393,0523,3554,2234,1122,9063,2693,8544,2772,8002,9173,7173,617-5,2412,7453,194
Net Income Margin-3.8%0.18*0.18*0.18*0.18*0.18*0.18*0.18*0.18*0.19*0.18*0.19*0.19*0.19*0.19*0.18*0.07*0.07*0.06*0.06*0.16*-
Free Cashflow7.6%4,2833,9794,6073,1332,8663,1803,0212,4994,4953,5523,4073,4314,8573,8894,1483,3333,7593,0903,3372,765-
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-1.5%120,709122,531120,829119,851117,715116,282117,208120,217121,416119,669119,307116,778120,112119,899120,700118,560111,723114,058115,095121,673123,687
  Current Assets-7.3%23,11124,94022,64822,30521,86622,52121,65323,41625,54524,33623,09122,60824,65526,02627,98727,14018,91721,92522,47322,31224,431
    Cash Equivalents-18.9%7,8909,7338,2467,5966,8546,7107,2148,52611,54410,37010,28810,00711,94113,39216,18115,3936,2799,3044,2392,7383,696
  Inventory0.5%7,1517,1177,0737,4837,5417,5906,9247,1016,6736,3075,9836,0025,9575,7075,4985,3305,5215,4655,0175,3585,281
  Net PPE2.3%22,13221,63621,90921,56421,16720,59321,19521,32321,35721,39221,68621,10321,41620,87620,69220,45921,25020,90121,27120,99320,822
  Goodwill1.7%40,91640,23940,65940,71839,95138,76139,70040,71040,31540,49340,92440,61241,38140,56939,90139,61739,99839,60540,27346,75346,932
Liabilities-3.5%71,88074,51773,76474,43072,99071,94870,35474,47176,52373,26172,65369,85971,57271,32373,82272,61965,81567,07467,51666,12169,244
  Current Liabilities-3.3%35,95037,15835,75638,03038,74636,61833,08134,40138,02736,58933,13232,01631,74430,00832,97632,89630,16430,25330,01128,37031,247
  Long Term Debt-4.0%23,09624,06924,37822,87420,58221,28622,84823,76722,32220,55823,09921,05322,51423,94823,53723,31018,98520,16120,39521,35921,514
    LT Debt, Non Current-4.0%23,09624,06924,37822,87420,58221,28622,84823,76722,32220,55823,09921,05322,51423,94823,53723,31018,98520,16120,39521,35921,514
Shareholder's Equity1.7%48,82948,01447,06545,42144,72544,33446,85445,74644,89346,40846,65446,91948,54048,57646,87845,94145,90846,98447,57955,55254,443
  Retained Earnings1.0%121,617120,443118,170117,082115,858114,163112,429111,645110,393108,361106,374105,674104,361102,539100,23999,47498,41496,62594,918102,103101,170
  Additional Paid-In Capital0.2%66,93566,82266,55666,31666,14565,95565,79565,61465,43265,14864,84864,68264,67264,46764,19463,97664,01963,94963,82763,62463,679
Shares Outstanding-0.2%2,3532,357-2,3572,3592,370-2,3992,3972,420-2,4482,4622,480-2,4762,4692,4942,5022,508-
Minority Interest-8.4%294321288281270259265268275297276323359394357401370406385480453
Float-----357,000---392,000---341,000---304,000----
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations4.0%5,1004,9045,3413,8633,5744,0703,7133,2465,1214,6434,1214,0875,4244,7394,8064,0644,3644,1694,1513,5174,007
  Share Based Compensation20.0%15012513915614510513013015211614214416589.0023312392.0011021611879.00
Cashflow From Investing18.0%-1,002-1,222-798-1,380-490-832-682-1,776-960-1,006-791-665-549-829-659-725-6505,079647573-3,845
Cashflow From Financing-196.8%-6,049-2,038-3,893-1,753-2,993-3,507-4,158-4,432-2,858-3,428-3,085-5,275-6,441-6,730-3,3995,945-6,795-4,118-3,304-5,0661,032
  Dividend Payments-0.1%2,2882,2902,2892,2242,2312,2552,2622,1552,1712,1822,1972,0112,0252,0302,0281,9061,9231,9321,9371,8581,850
  Buy Backs-33.1%1,0031,500-1,3512,0024,0001,2501,2494,7542,7503,0003,0013,0082,000-9013,5043,0001,7501,250751

PG Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
$ in Millions
3 Months Ended6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Net Sales$ 21,441$ 20,773$ 43,312$ 41,385
Cost of Products Sold10,14410,89720,64521,743
Selling, General and Administrative Expense5,5225,09111,1279,918
Impairment of Intangible Assets for Grooming Segment, Indefinite-Lived (Excluding Goodwill)1,34101,3410
Operating Income4,4334,78510,2009,724
Interest Expense(248)(171)(472)(294)
Interest Income13366262108
Other Non-operating Income/(Loss), Net177155309294
Earnings/(Loss) from Continuing Operations Before Income Taxes4,4964,83510,2999,832
Income Taxes on Continuing Operations1,0038762,2501,910
Net Earnings3,4933,9598,0497,922
Net Income (Loss) Attributable to Noncontrolling Interest25266050
Net Income (Loss) Attributable to Parent$ 3,468$ 3,933$ 7,988$ 7,872
Basic Net Earnings Per Common Share    
Basic Net Earnings/(Loss) Per Common Share[1]$ 1.44[2]$ 1.63[2]$ 3.33$ 3.25
Diluted Net Earnings Per Common Share    
Diluted Net Earnings/(Loss) Per Common Share[1]$ 1.40[2]$ 1.59[2]$ 3.23$ 3.16
[1]Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.
[2]Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter & Gamble.

PG Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Millions, $ in Millions
Dec. 31, 2023
Jun. 30, 2023
Current Assets  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents$ 7,890$ 8,246
Accounts Receivable6,3345,471
Inventories  
Materials and Supplies1,7801,863
Work in Process962956
Finished Goods4,4104,254
Total Inventories7,1517,073
Prepaid Expenses and Other Current Assets1,7361,858
Total Current Assets23,11122,648
Property, Plant and Equipment, Net22,13221,909
Goodwill40,91640,659
Trademarks and Other Intangible Assets, Net22,30223,783
Other Noncurrent Assets12,24811,830
Total Assets120,709120,829
Current Liabilities  
Accounts Payable14,23414,598
Accrued and Other Liabilities11,10010,929
Debt Due Within One Year10,61610,229
Total Current Liabilities35,95035,756
Long-Term Debt23,09624,378
Deferred Income Tax Liabilities, Net6,2196,478
Other Noncurrent Liabilities6,6147,152
Total Liabilities71,88073,764
Shareholders' Equity  
Preferred Stock$ 809$ 819
Common Stock, Shares, Issued4,009.24,009.2
Common Stock, Value, Issued$ 4,009$ 4,009
Additional Paid in Capital66,93566,556
Reserve For ESOP Debt Retirement(782)(821)
Accumulated Other Comprehensive Income/(Loss)(12,167)(12,220)
Treasury Stock(131,887)(129,736)
Retained Earnings121,617118,170
Noncontrolling Interest294288
Total Shareholders' Equity48,82947,065
Total Liabilities and Shareholders' Equity$ 120,709$ 120,829
PG
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.
 CEO
 WEBSITEwww.pginvestor.com
 EMPLOYEES65535

Procter & Gamble Co-The Frequently Asked Questions


What is the ticker symbol for Procter & Gamble Co-The? What does PG stand for in stocks?

PG is the stock ticker symbol of Procter & Gamble Co-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Procter & Gamble Co-The (PG)?

As of Thu Feb 22 2024, market cap of Procter & Gamble Co-The is 377.78 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PG stock?

You can check PG's fair value in chart for subscribers.

What is the fair value of PG stock?

You can check PG's fair value in chart for subscribers. The fair value of Procter & Gamble Co-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Procter & Gamble Co-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Procter & Gamble Co-The a good stock to buy?

The fair value guage provides a quick view whether PG is over valued or under valued. Whether Procter & Gamble Co-The is cheap or expensive depends on the assumptions which impact Procter & Gamble Co-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PG.

What is Procter & Gamble Co-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Feb 22 2024, PG's PE ratio (Price to Earnings) is 25.58 and Price to Sales (PS) ratio is 4.5. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PG PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Procter & Gamble Co-The's stock?

In the past 10 years, Procter & Gamble Co-The has provided 0.099 (multiply by 100 for percentage) rate of return.